Predictive Factors for Survival in Aggressive Meningiomas

Recruiting now · Not applicable

Conditions studied: Meningioma, Meningioma Atypical, Anaplastic Meningioma

In brief

The investigators plan to collect clinical and molecular data, including ICH, PCR, NGS and methylome, from patients operated on for grade 2 or grade 3 meningioma. The purpose of the study is to identify reliable and easy-to-assess predictive factors for recurrence and survival after surgery.

Key facts

Study ID

NCT05793034

Run by

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

People needed

250

Starts

2021-01-07

Expected to finish

2027-01-07

Last updated by the study team

2025-03-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient operated for atypical (grade 2) meningioma; or
• Patient operated for anaplastic (grade 3) meningioma;
• Timeframe for surgery, 1999-2019

You may not qualify if…

• Patient lost at follow-up

Where it is running

• Fondazione Policlinico Universitario A. Gemelli IRCCS — Rome, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.